G01N 33/5008
For testing or evaluating the effect of chemical or biological compounds
Official title: {for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics}
G01N33/5008 (For testing or evaluating the effect of chemical or biological compounds) appears on 10,153 US grants and 20,184 published applications in this corpus.
Search patents in G01N- Granted patents
- 10,153
- Published applications
- 20,184
- Assignees
- 5,640
- Inventors
- 34,127
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 3 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 6 | 0 |
| 1988 | 11 | 0 |
| 1989 | 11 | 0 |
| 1990 | 6 | 0 |
| 1991 | 16 | 0 |
| 1992 | 15 | 0 |
| 1993 | 28 | 0 |
| 1994 | 29 | 0 |
| 1995 | 26 | 0 |
| 1996 | 55 | 0 |
| 1997 | 90 | 0 |
| 1998 | 135 | 0 |
| 1999 | 168 | 0 |
| 2000 | 120 | 0 |
| 2001 | 167 | 52 |
| 2002 | 161 | 400 |
| 2003 | 167 | 1533 |
| 2004 | 141 | 627 |
| 2005 | 135 | 671 |
| 2006 | 278 | 696 |
| 2007 | 286 | 743 |
| 2008 | 327 | 615 |
| 2009 | 256 | 756 |
| 2010 | 349 | 766 |
| 2011 | 345 | 751 |
| 2012 | 370 | 741 |
| 2013 | 388 | 763 |
| 2014 | 448 | 907 |
| 2015 | 476 | 964 |
| 2016 | 504 | 943 |
| 2017 | 529 | 918 |
| 2018 | 567 | 922 |
| 2019 | 539 | 943 |
| 2020 | 559 | 921 |
| 2021 | 443 | 960 |
| 2022 | 441 | 921 |
| 2023 | 398 | 764 |
| 2024 | 441 | 814 |
| 2025 | 409 | 659 |
| 2026 | 292 | 434 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Bioactive agents and methods related thereto6 Oct 2026US 12,753,216 B2Aroa Biosurgery Limited
- Liquid crystal scaffolds and use thereof for organoid, spheroid, and 3D cellaggregate manufacturing6 Oct 2026US 12,753,393 B2The Regents of the University of California
- Single-cell-based electrochemical sensor based on functionalized nano-probe and application thereof6 Oct 2026US 12,754,158 B2Jiangnan University
- Monoclonal antibody drug sensitivity in multiple myeloma patients6 Oct 2026US 12,754,180 B2The Regents of the University of Colorado, a body corporate
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Trem2 agonists for the stimulation of microglia and methods of identification8 Oct 2026US 2026/0306439 A1The Translational Genomics Research Institute
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Molecular-genetic strategy for the reactivation of juvenile plasticity in targeted adult neural circuits8 Oct 2026US 2026/0306662 A1The Regents of the University of California
Most cited
By later US patents
- High throughput screening assay systems in microscale fluidic devices877US 5,942,443 ACaliper Technologies Corp. · 1999
- Patient classification703US 6,763,307 B2Bioseek, Inc. · 2004
- High throughput screening assay systems in microscale fluidic devices692US 6,046,056 ACaliper Technologies Corp. · 2000
- Transgenic non-human mammals531US 4,736,866 APresident and Fellows of Harvard College · 1988
- High throughput screening assay systems in microscale fluidic devices353US 6,267,858 B1Caliper Technologies Corp. · 2001